{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:19:41Z","timestamp":1772547581854,"version":"3.50.1"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.eplepsyres.2018.10.011","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T23:02:09Z","timestamp":1540508529000},"page":"13-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Modeling and simulation for the evaluation of dose adaptation rules of intravenous lacosamide in children"],"prefix":"10.1016","volume":"149","author":[{"given":"Julia","family":"Winkler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7538-3005","authenticated-orcid":false,"given":"Rik","family":"Schoemaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0815-5264","authenticated-orcid":false,"given":"Armel","family":"Stockis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2018.10.011_bib0005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000339077","article-title":"Bioequivalence of intravenous and oral formulations of the antiepileptic drug lacosamide","volume":"90","author":"Cawello","year":"2012","journal-title":"Pharmacology"},{"key":"10.1016\/j.eplepsyres.2018.10.011_bib0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/nyas.12513","article-title":"Advances in epilepsy treatment: lacosamide pharmacokinetic profile","volume":"1329","author":"Cawello","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.eplepsyres.2018.10.011_bib0015","doi-asserted-by":"crossref","first-page":"s56","DOI":"10.1016\/S1090-3798(15)30186-0","article-title":"Safety and tolerability of lacosamide as adjunctive therapy in children with partial-onset seizures","volume":"19","author":"Ferreira","year":"2015","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2018.10.011_bib0020","series-title":"Vimpat\u00ae (lacosamide Tablets, Injection, Oral Solution) [U.S. Prescribing Information]","author":"UCB Pharma","year":"2018"},{"key":"10.1016\/j.eplepsyres.2018.10.011_bib0025","series-title":"Vimpat\u00ae (lacosamide) EMA Summary of Product Characteristics","author":"UCB Pharma","year":"2018"},{"issue":"Suppl. 1","key":"10.1016\/j.eplepsyres.2018.10.011_bib0030","first-page":"177","article-title":"Lacosamide population pharmacokinetics in children from 6 months to 17 years of age","volume":"56","author":"Winkler","year":"2015","journal-title":"Epilepsia"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121118302572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121118302572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:39:32Z","timestamp":1760276372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121118302572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":6,"alternative-id":["S0920121118302572"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.10.011","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling and simulation for the evaluation of dose adaptation rules of intravenous lacosamide in children","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}